Momordica charantia for type 2 diabetes mellitus (Q24201473)

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

The burden and costs of chronic diseases in low-income and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

An approach to the management of unintentional weight loss in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Traditional plant medicines as treatments for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Chemical composition and antimicrobial activity of Momordica charantia seed essential oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and low-carbohydrate diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

A Coefficient of Agreement for Nominal Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Food and drug interaction: consequences for the nutrition/health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Medicinal plants of India with anti-diabetic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

The case of the misleading funnel plot

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution"

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Leads from Indian medicinal plants with hypoglycemic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Pharmacodynamic interaction of Momordica charantia with rosiglitazone in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Use of the equivalence approach in reproductive health clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Application of modified in vitro screening procedure for identifying herbals possessing sulfonylurea-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

The burden and treatment of diabetes in elderly individuals in the u.s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Investigating and Dealing with Publication and Other Biases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Disability trends among elderly persons and implications for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Screening of Turkish anti-ulcerogenic folk remedies for anti-Helicobacter pylori activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

The termination of early pregnancy in the mouse by beta-momorcharin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

7 January 2021

The inhibitory effects of beta-momorcharin on endometrial cells in the mouse

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

7 January 2021

Effects of momorcharins on the mouse embryo at the early organogenesis stage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

7 January 2021

Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

7 January 2021

Diabetes mellitus: perspective from the Asia-Pacific region

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

7 January 2021

Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

7 January 2021

Hypoglycemic Activity of Polypeptide-p From a Plant Source

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

7 January 2021

Muscle strength and functional mobility in relation to lean body mass in free-living frail elderly women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

7 January 2021

Improvement in glucose tolerance due to Momordica charantia (karela)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

7 January 2021

Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007845.PUB3

7 January 2021